Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles

DOI: 10.1080/2162402X.2017.1362530

Keywords: exosomes, immune evasion, neo-adjuvant clinical trial, Neuromedin U

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text